[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C][C][C][Branch1][Ring2][C][Ring1][Branch1][Branch1][Ring1][C][#N][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][N][C][=Branch1][C][=O][C][=C][Branch1][#Branch1][N][=C][C][=C][Ring1][=Branch1][N][C][C][=C][C][=N][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. Upon administration, rivoceranib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases."}]